The scales are moving for the first time in years. The food noise has gone quiet. If you are a woman in your 40s or 50s on Mounjaro, Wegovy or another GLP-1 medication, I am not here to take any of that away from you. If it is working for you, I am not here to argue with that.
I am here to tell you about the bit that fits in nobody’s ten-minute appointment.
Not all the weight you lose is fat
When weight falls quickly, the body sheds a mixture of tissues. In the tirzepatide trial data, around a quarter of the weight lost was lean tissue rather than fat. With semaglutide it was closer to 40 per cent. Lean tissue is not only muscle, it includes water and organ mass, but muscle is a large part of it.
On its own, that is a known trade-off of any rapid weight loss, medicated or not. What makes it different for you is timing.
Menopause was already coming for your muscle
From the mid-40s, falling oestrogen accelerates two quiet processes: muscle loss and bone thinning. Women lose muscle faster through the menopause transition than at almost any other point in adult life, and bone density follows the same slope.
So a woman of 49 on a GLP-1 is running two muscle-losing processes at the same time. The medication does not know that. The online pharmacy that prescribed it in a seven-minute consultation almost certainly did not ask.
And muscle in midlife is not about how your arms look. It is the largest disposal site for blood glucose, a major driver of your resting metabolic rate, and the single best predictor of staying strong, independent and off the orthopaedic ward in your later decades. Muscle is the organ of longevity. Losing a meaningful share of that reserve over a few months, at the age when it is already declining, is a poor exchange for a smaller number on the scales.
The good news: this is preventable, not inevitable
The research on protecting lean mass during rapid weight loss is consistent, and none of it is exotic.
Protein, front and centre. Appetite suppression makes protein the first thing to slide. Most midlife women on GLP-1s I see are eating half of what their muscle needs. The target is meaningfully higher than the standard guideline, spread across the day rather than loaded into one evening meal, and it has to be planned, because on a suppressed appetite it will not happen by accident.
Resistance training, non-negotiable. Protein is the building material; lifting is the instruction to keep the building. Walking is wonderful and it is not enough. Two or three structured strength sessions a week is the difference between losing weight and losing yourself.
Micronutrients on a small appetite. Fewer meals means fewer chances at calcium, vitamin D, B12, iron and fibre, all of which matter more, not less, through menopause. This is a design problem, and it is solvable.
An exit plan. The most dangerous window is after the last injection, when appetite returns and the habits that were supposed to be built during the quiet months were never built. Coming off well is planned months in advance, not the week the prescription ends.
What I would ask before trusting anyone with this
The GLP-1 gold rush has filled the internet with advice. Some questions that sort the clinicians from the content creators: Are they registered (AFN, SENr or equivalent, on a register you can check)? Do they talk about muscle, bone and function, or only about weight? Will they work alongside your prescriber rather than around them? Do they measure anything?
If the answers are no, keep your money.
The point
The medication has one job and it is doing it. Protecting the body that comes out the other side, the muscle, the bone, the energy to actually live in it, was never the drug’s job. It is yours, and it is very doable with the right support.
If you are on a GLP-1, or considering one, and you want the menopause-literate clinical version of that support, that is exactly what I do. Or start with a free clarity call.
This article is educational and is not medical advice. Decisions about starting, continuing or stopping any medication belong with you and your prescribing clinician.